{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:57:41Z","timestamp":1777611461572,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA102667"],"award-info":[{"award-number":["R01CA102667"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA239588"],"award-info":[{"award-number":["R01CA239588"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["Contract No. 75N91019D00024"],"award-info":[{"award-number":["Contract No. 75N91019D00024"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in sub-Saharan African children can range up to 50% by age 2 years but factors affecting early age of KSHV infection are not well understood. Malaria during pregnancy has been associated with hindered transplacental transfer of antibodies to several pathogens but whether it affects transplacental transfer of KSHV antibodies is unknown. We aimed to determine if <jats:italic>in utero<\/jats:italic> malaria exposure reduced the transfer of KSHV antibodies across the placenta.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A cohort study in Kisumu, Kenya enrolled pregnant women at their first antenatal clinic (ANC) visit and followed them through delivery. We included 70 KSHV-positive, HIV-negative mothers and their children. KSHV antibody levels were measured by ELISA (K8.1, ORF73) and multiplex assay (K8.1, ORF73, K10.5, ORF38, ORF50). Transplacental transfer of antibodies was measured by the cord to maternal blood ratio (CMR) of KSHV antibodies. Malaria during pregnancy was defined as detection of <jats:italic>Plasmodium falciparum<\/jats:italic> (<jats:italic>Pf<\/jats:italic>) DNA at any ANC visit or delivery. Among women with malaria during pregnancy, we examined time of last malaria infection prior to delivery (&lt;\u200927 vs. 27+ weeks gestation) and malaria incidence rate (MIR) (episodes\/100 person-weeks).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>KSHV seroprevalence (positive for K8.1 or ORF73 by ELISA) among pregnant women was 88%. Neither malaria during pregnancy, malaria infection timing, nor MIR were associated with maternal delivery KSHV antibody blood levels. Maternal delivery and cord blood KSHV antibody levels were highly correlated but these correlations did not differ by malaria during pregnancy. KSHV transplacental antibody transfer was not associated with malaria during pregnancy, malaria infection timing, nor MIR.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Malaria during pregnancy does not appear to affect transfer of KSHV antibodies across the placenta.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13027-020-00336-1","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T11:04:57Z","timestamp":1606388697000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Malaria during pregnancy and transplacental transfer of Kaposi sarcoma-associated herpesvirus (KSHV) antibodies: a cohort study of Kenyan mother and child pairs"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6147-9196","authenticated-orcid":false,"given":"Katherine R.","family":"Sabourin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidney","family":"Ogolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim I.","family":"Daud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conner L.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendell","family":"Miley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazzarena","family":"Labo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Whitby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary","family":"Rochford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,26]]},"reference":[{"key":"336_CR1","unstructured":"International Agency for Research on Cancer (IARC). The Global Cancer Observatory (GCO). Kenya Fact Sheet: Globocan 2018. Edited by International Agency for Research on Cancer. Lyon: International Agency for Research on Cancer, World Health Organization; 2020."},{"issue":"7","key":"336_CR2","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/infdis\/jiy274","volume":"218","author":"A Nalwoga","year":"2018","unstructured":"Nalwoga A, Cose S, Nash S, Miley W, Asiki G, Kusemererwa S, Yarchoan R, Labo N, Whitby D, Newton R. Relationship between Anemia, malaria Coinfection, and Kaposi sarcoma-associated Herpesvirus Seropositivity in a population-based study in rural Uganda. J Infect Dis. 2018;218(7):1061\u20135.","journal-title":"J Infect Dis"},{"issue":"7","key":"336_CR3","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1093\/infdis\/jix399","volume":"216","author":"KL Crabtree","year":"2017","unstructured":"Crabtree KL, Wojcicki JM, Minhas V, Kankasa C, Mitchell C, Wood C. Association of Household Food- and Drink-Sharing Practices with Human Herpesvirus 8 Seroconversion in a cohort of Zambian children. J Infect Dis. 2017;216(7):842\u20139.","journal-title":"J Infect Dis"},{"issue":"4","key":"336_CR4","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1086\/519845","volume":"196","author":"P Cumberland","year":"2007","unstructured":"Cumberland P, Shulman CE, Maple PA, Bulmer JN, Dorman EK, Kawuondo K, Marsh K, Cutts FT. Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya. J Infect Dis. 2007;196(4):550\u20137.","journal-title":"J Infect Dis"},{"issue":"5","key":"336_CR5","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1086\/322808","volume":"184","author":"BJ Okoko","year":"2001","unstructured":"Okoko BJ, Wesumperuma LH, Ota MO, Pinder M, Banya W, Gomez SF, McAdam KP, Hart AC. The influence of placental malaria infection and maternal hypergammaglobulinemia on transplacental transfer of antibodies and IgG subclasses in a rural west African population. J Infect Dis. 2001;184(5):627\u201332.","journal-title":"J Infect Dis"},{"issue":"8891","key":"336_CR6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0140-6736(94)90991-1","volume":"343","author":"ME Brair","year":"1994","unstructured":"Brair ME, Brabin BJ, Milligan P, Maxwell S, Hart CA. Reduced transfer of tetanus antibodies with placental malaria. Lancet. 1994;343(8891):208\u20139.","journal-title":"Lancet"},{"issue":"2","key":"336_CR7","first-page":"59","volume":"19","author":"BJ Okoko","year":"2001","unstructured":"Okoko BJ, Wesuperuma LH, Ota MO, Banya WA, Pinder M, Gomez FS, Osinusi K, Hart AC. Influence of placental malaria infection and maternal hypergammaglobulinaemia on materno-foetal transfer of measles and tetanus antibodies in a rural west African population. J Health Popul Nutr. 2001;19(2):59\u201365.","journal-title":"J Health Popul Nutr"},{"issue":"3","key":"336_CR8","doi-asserted-by":"publisher","first-page":"F202","DOI":"10.1136\/fn.79.3.F202","volume":"79","author":"MI de Moraes-Pinto","year":"1998","unstructured":"de Moraes-Pinto MI, Verhoeff F, Chimsuku L, Milligan PJ, Wesumperuma L, Broadhead RL, Brabin BJ, Johnson PM, Hart CA. Placental antibody transfer: influence of maternal HIV infection and placental malaria. Arch Dis Child Fetal Neonatal Ed. 1998;79(3):F202\u20135.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"11","key":"336_CR9","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1128\/CVI.00270-15","volume":"22","author":"S Ogolla","year":"2015","unstructured":"Ogolla S, Daud II, Asito AS, Sumba OP, Ouma C, Vulule J, Middeldorp JM, Dent AE, Mehta S, Rochford R. Reduced Transplacental transfer of a subset of Epstein-Barr virus-specific antibodies to neonates of mothers infected with plasmodium falciparum malaria during pregnancy. Clin Vaccine Immunol. 2015;22(11):1197\u2013205.","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"336_CR10","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s10995-014-1546-4","volume":"19","author":"II Daud","year":"2015","unstructured":"Daud II, Ogolla S, Amolo AS, Namuyenga E, Simbiri K, Bukusi EA, Ng'ang'a ZW, Ploutz-Snyder R, Sumba PO, Dent A, et al. Plasmodium falciparum infection is associated with Epstein-Barr virus reactivation in pregnant women living in malaria holoendemic area of Western Kenya. Matern Child Health J. 2015;19(3):606\u201314.","journal-title":"Matern Child Health J"},{"issue":"6","key":"336_CR11","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/infdis\/jiv525","volume":"213","author":"A Reynaldi","year":"2016","unstructured":"Reynaldi A, Schlub TE, Chelimo K, Sumba PO, Piriou E, Ogolla S, Moormann AM, Rochford R, Davenport MP. Impact of plasmodium falciparum Coinfection on longitudinal Epstein-Barr virus kinetics in Kenyan children. J Infect Dis. 2016;213(6):985\u201391.","journal-title":"J Infect Dis"},{"issue":"4","key":"336_CR12","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1128\/CDLI.10.4.631-636.2003","volume":"10","author":"S Chaisavaneeyakorn","year":"2003","unstructured":"Chaisavaneeyakorn S, Moore JM, Mirel L, Othoro C, Otieno J, Chaiyaroj SC, Shi YP, Nahlen BL, Lal AA, Udhayakumar V. Levels of macrophage inflammatory protein 1 alpha (MIP-1 alpha) and MIP-1 beta in intervillous blood plasma samples from women with placental malaria and human immunodeficiency virus infection. Clin Diagn Lab Immunol. 2003;10(4):631\u20136.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1\u20132","key":"336_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jim.2010.02.015","volume":"356","author":"GL Mbisa","year":"2010","unstructured":"Mbisa GL, Miley W, Gamache CJ, Gillette WK, Esposito D, Hopkins R, Busch MP, Schreiber GB, Little RF, Yarchoan R, et al. Detection of antibodies to Kaposi's sarcoma-associated herpesvirus: a new approach using K8.1 ELISA and a newly developed recombinant LANA ELISA. J Immunol Methods. 2010;356(1\u20132):39\u201346.","journal-title":"J Immunol Methods"},{"issue":"3","key":"336_CR14","doi-asserted-by":"publisher","first-page":"e1004046","DOI":"10.1371\/journal.ppat.1004046","volume":"10","author":"N Labo","year":"2014","unstructured":"Labo N, Miley W, Marshall V, Gillette W, Esposito D, Bess M, Turano A, Uldrick T, Polizzotto MN, Wyvill KM, et al. Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteome. PLoS Pathog. 2014;10(3):e1004046.","journal-title":"PLoS Pathog"},{"key":"336_CR15","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3389\/fimmu.2017.01294","volume":"8","author":"CR Wilcox","year":"2017","unstructured":"Wilcox CR, Holder B, Jones CE. Factors affecting the FcRn-mediated Transplacental transfer of antibodies and implications for vaccination in pregnancy. Front Immunol. 2017;8:1294.","journal-title":"Front Immunol"},{"key":"336_CR16","first-page":"338","volume":"7","author":"B Abu-Raya","year":"2016","unstructured":"Abu-Raya B, Smolen KK, Willems F, Kollmann TR, Marchant A. Transfer of maternal antimicrobial immunity to HIV-exposed uninfected newborns. Front Immunol. 2016;7:338.","journal-title":"Front Immunol"},{"issue":"6","key":"336_CR17","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/infdis\/jir872","volume":"205","author":"E Piriou","year":"2012","unstructured":"Piriou E, Asito AS, Sumba PO, Fiore N, Middeldorp JM, Moormann AM, Ploutz-Snyder R, Rochford R. Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma. J Infect Dis. 2012;205(6):906\u201313.","journal-title":"J Infect Dis"},{"issue":"8","key":"336_CR18","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1086\/428910","volume":"191","author":"AM Moormann","year":"2005","unstructured":"Moormann AM, Chelimo K, Sumba OP, Lutzke ML, Ploutz-Snyder R, Newton D, Kazura J, Rochford R. Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children. J Infect Dis. 2005;191(8):1233\u20138.","journal-title":"J Infect Dis"},{"issue":"3","key":"336_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/ijc.2910220304","volume":"22","author":"RJ Biggar","year":"1978","unstructured":"Biggar RJ, Henle W, Fleisher G, Bocker J, Lennette ET, Henle G. Primary Epstein-Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection. Int J Cancer. 1978;22(3):239\u201343.","journal-title":"Int J Cancer"},{"key":"336_CR20","unstructured":"World Health Organization (WHO): Malaria Country Profiles: Kenya. In: Malaria Country Profiles; Edited by World Health Organization. Geneva: World Health Organization (WHO); 2018."},{"key":"336_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1750-9378-6-15","volume":"6","author":"K Wakeham","year":"2011","unstructured":"Wakeham K, Webb EL, Sebina I, Muhangi L, Miley W, Johnson WT, Ndibazza J, Elliott AM, Whitby D, Newton R. Parasite infection is associated with Kaposi's sarcoma associated herpesvirus (KSHV) in Ugandan women. Infect Agent Cancer. 2011;6:15.","journal-title":"Infect Agent Cancer"},{"issue":"5","key":"336_CR22","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/tmi.12464","volume":"20","author":"A Nalwoga","year":"2015","unstructured":"Nalwoga A, Cose S, Wakeham K, Miley W, Ndibazza J, Drakeley C, Elliott A, Whitby D, Newton R. Association between malaria exposure and Kaposi's sarcoma-associated herpes virus seropositivity in Uganda. Tropical Med Int Health. 2015;20(5):665\u201372.","journal-title":"Tropical Med Int Health"},{"issue":"2","key":"336_CR23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/QAI.0b013e31828a7056","volume":"63","author":"K Wakeham","year":"2013","unstructured":"Wakeham K, Webb EL, Sebina I, Nalwoga A, Muhangi L, Miley W, Johnston WT, Ndibazza J, Whitby D, Newton R, et al. Risk factors for seropositivity to Kaposi sarcoma-associated herpesvirus among children in Uganda. J Acquir Immune Defic Syndr. 2013;63(2):228\u201333.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"336_CR24","doi-asserted-by":"crossref","unstructured":"Nalwoga A, Nakibuule M, Marshall V, Miley W, Labo N, Cose S, Whitby D, Newton R. Risk factors for Kaposi's sarcoma associated herpesvirus (KSHV) DNA in blood and in saliva in rural Uganda. Clin Infect Dis. 2019;71(4):1055-62.","DOI":"10.1093\/cid\/ciz916"},{"issue":"10","key":"336_CR25","doi-asserted-by":"publisher","first-page":"e0007776","DOI":"10.1371\/journal.pntd.0007776","volume":"13","author":"A Nalwoga","year":"2019","unstructured":"Nalwoga A, Webb EL, Chihota B, Miley W, Walusimbi B, Nassuuna J, Sanya RE, Nkurunungi G, Labo N, Elliott AM, et al. Kaposi\u2019s sarcoma-associated herpesvirus seropositivity is associated with parasite infections in Ugandan fishing communities on Lake Victoria islands. PLoS Negl Trop Dis. 2019;13(10):e0007776.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"336_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.canep.2014.02.006","volume":"38","author":"K Stolka","year":"2014","unstructured":"Stolka K, Ndom P, Hemingway-Foday J, Iriondo-Perez J, Miley W, Labo N, Jennifer S, Abassora M, Woelk G, Ryder R, et al. Risk factors for Kaposi\u2019s sarcoma among HIV-positive individuals in a case control study in Cameroon. Cancer Epidemiol. 2014;38(2):137\u201343.","journal-title":"Cancer Epidemiol"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-020-00336-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13027-020-00336-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-020-00336-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T11:30:07Z","timestamp":1606390207000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/s13027-020-00336-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,26]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["336"],"URL":"https:\/\/doi.org\/10.1186\/s13027-020-00336-1","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,26]]},"assertion":[{"value":"29 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent was obtained from each study participant. Research was performed in accordance with the Declaration of Helsinki and was approved by the appropriate ethics committees. The data from the parent study is still under analysis and will be released publicly when analyses have been completed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}